News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
243,861 Results
Type
Article (5660)
Company Profile (19)
Press Release (238182)
Section
Business (86485)
Career Advice (476)
Deals (15868)
Drug Delivery (9)
Drug Development (22337)
Employer Resources (35)
FDA (3952)
Job Trends (4258)
News (128657)
Policy (8143)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (361)
Accelerated approval (2)
Adcomms (3)
Allergies (12)
Alliances (15736)
ALS (25)
Alzheimer's disease (309)
Antibody-drug conjugate (ADC) (12)
Approvals (3965)
Artificial intelligence (51)
Autoimmune disease (4)
Automation (4)
Bankruptcy (105)
Best Places to Work (3142)
Biosimilars (12)
Biotechnology (24)
Bladder cancer (9)
Brain cancer (8)
Breast cancer (62)
Cancer (540)
Cardiovascular disease (27)
Career advice (407)
Career pathing (4)
CAR-T (38)
Cell therapy (119)
Cervical cancer (3)
Clinical research (18739)
Collaboration (194)
Compensation (218)
Complete response letters (2)
COVID-19 (357)
CRISPR (8)
C-suite (114)
Cystic fibrosis (17)
Data (649)
Depression (7)
Diabetes (58)
Diagnostics (2236)
Digital health (3)
Diversity, equity & inclusion (13)
Drug discovery (20)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (42394)
Editorial (2)
Employer branding (8)
Employer resources (36)
Events (42723)
Executive appointments (342)
FDA (4252)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (208)
Gene editing (18)
Generative AI (4)
Gene therapy (63)
GLP-1 (113)
Government (495)
Guidances (19)
Healthcare (5691)
Huntington's disease (1)
IgA nephropathy (6)
Immunology and inflammation (17)
Indications (7)
Infectious disease (379)
Inflammatory bowel disease (29)
Inflation Reduction Act (2)
Influenza (6)
Intellectual property (17)
Interviews (54)
IPO (8361)
IRA (3)
Job creations (1202)
Job search strategy (374)
Kidney cancer (7)
Labor market (5)
Layoffs (105)
Leadership (6)
Legal (2432)
Liver cancer (19)
Lung cancer (64)
Lymphoma (35)
Management (11)
Manufacturing (58)
MASH (33)
Medical device (4299)
Medtech (4301)
Mergers & acquisitions (7763)
Metabolic disorders (152)
Multiple sclerosis (11)
NASH (6)
Neurodegenerative disease (11)
Neuropsychiatric disorders (3)
Neuroscience (430)
NextGen: Class of 2025 (1814)
Non-profit (818)
Northern California (1115)
Now hiring (4)
Obesity (61)
Opinion (32)
Ovarian cancer (19)
Pain (15)
Pancreatic cancer (22)
Parkinson's disease (39)
Partnered (4)
Patents (28)
Patient recruitment (33)
Peanut (5)
People (26214)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (5697)
Phase II (8407)
Phase III (6259)
Pipeline (596)
Policy (10)
Postmarket research (653)
Preclinical (2252)
Press Release (66)
Prostate cancer (32)
Psychedelics (3)
Radiopharmaceuticals (115)
Rare diseases (79)
Real estate (1982)
Recruiting (11)
Regulatory (5637)
Reports (14)
Research institute (363)
Resumes & cover letters (69)
Rett syndrome (3)
Schizophrenia (25)
Series A (30)
Series B (25)
Sickle cell disease (13)
Southern California (899)
Special edition (1)
Spinal muscular atrophy (29)
Sponsored (4)
Startups (1119)
Stomach cancer (1)
Supply chain (12)
Tariffs (5)
United States (8329)
Vaccines (47)
Venture capitalists (3)
Weight loss (23)
Women's health (1)
Date
Today (48)
Last 7 days (244)
Last 30 days (815)
Last 365 days (11627)
2025 (3495)
2024 (12797)
2023 (15372)
2022 (21264)
2021 (22419)
2020 (20288)
2019 (14321)
2018 (10877)
2017 (10757)
2016 (9640)
2015 (12756)
2014 (10066)
2013 (8048)
2012 (8628)
2011 (9109)
2010 (8940)
Location
Africa (196)
Alabama (14)
Alaska (2)
Arizona (60)
Arkansas (1)
Asia (12922)
Australia (1905)
California (2409)
Canada (765)
China (79)
Colorado (96)
Connecticut (93)
Delaware (30)
Europe (27543)
Florida (317)
Georgia (37)
Idaho (23)
Illinois (132)
India (8)
Indiana (81)
Iowa (2)
Japan (75)
Kansas (25)
Kentucky (11)
Louisiana (5)
Maine (40)
Maryland (255)
Massachusetts (1794)
Michigan (88)
Minnesota (151)
Mississippi (1)
Missouri (25)
Montana (17)
Nebraska (12)
Nevada (33)
New Hampshire (15)
New Jersey (667)
New Mexico (5)
New York (594)
North Carolina (397)
North Dakota (2)
Northern California (1115)
Ohio (59)
Oklahoma (5)
Oregon (5)
Pennsylvania (430)
Puerto Rico (2)
Rhode Island (13)
South America (286)
South Carolina (5)
Southern California (899)
Tennessee (40)
Texas (270)
Utah (74)
Virginia (48)
Washington D.C. (10)
Washington State (183)
West Virginia (2)
Wisconsin (22)
243,861 Results for "edwards lifesciences corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Edwards Lifesciences Reports Fourth Quarter Results
February 12, 2025
·
19 min read
Press Releases
Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference
February 25, 2025
·
1 min read
Deals
Edwards Lifesciences to Sell Critical Care to BD
Edwards Lifesciences announced it has entered into a definitive agreement to sell its Critical Care product group to BD, in an all-cash transaction valued at $4.2 billion.
June 3, 2024
·
5 min read
Business
Edwards Lifesciences Reports First Quarter 2024 Results
Edwards Lifesciences reported financial results for the quarter ended March 31, 2024.
April 25, 2024
·
20 min read
Press Releases
Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 7, 2025
·
1 min read
Press Releases
Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference
December 4, 2024
·
13 min read
Biotech Beach
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen Healthcare Conference on Tuesday, March 5, 2024.
February 23, 2024
·
1 min read
Business
Edwards Lifesciences Reports Fourth Quarter 2023 Results
Edwards Lifesciences reported financial results for the quarter ended December 31, 2023.
February 6, 2024
·
24 min read
Business
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2024 after the market closes on Thursday, April 25, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results.
April 18, 2024
·
1 min read
Business
Edwards Lifesciences to Host Earnings Conference Call on October 24, 2024
October 17, 2024
·
1 min read
1 of 24,387
Next
